Logo image of MATV

MATIV HOLDINGS INC (MATV) Stock Fundamental Analysis

USA - NYSE:MATV - US8085411069 - Common Stock

11.75 USD
-0.44 (-3.61%)
Last: 9/23/2025, 3:23:04 PM
Fundamental Rating

3

Taking everything into account, MATV scores 3 out of 10 in our fundamental rating. MATV was compared to 83 industry peers in the Chemicals industry. Both the profitability and financial health of MATV have multiple concerns. MATV has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

MATV had positive earnings in the past year.
MATV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MATV reported negative net income in multiple years.
MATV had a positive operating cash flow in each of the past 5 years.
MATV Yearly Net Income VS EBIT VS OCF VS FCFMATV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

MATV has a Return On Assets of -21.89%. This is amonst the worse of the industry: MATV underperforms 85.54% of its industry peers.
The Return On Equity of MATV (-109.10%) is worse than 86.75% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.46%, MATV is doing worse than 69.88% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MATV is below the industry average of 6.34%.
Industry RankSector Rank
ROA -21.89%
ROE -109.1%
ROIC 1.46%
ROA(3y)-4.64%
ROA(5y)-1%
ROE(3y)-13%
ROE(5y)-2.64%
ROIC(3y)1.6%
ROIC(5y)3.28%
MATV Yearly ROA, ROE, ROICMATV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

With a Operating Margin value of 1.68%, MATV is not doing good in the industry: 73.49% of the companies in the same industry are doing better.
MATV's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 17.66%, MATV is not doing good in the industry: 69.88% of the companies in the same industry are doing better.
MATV's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.68%
PM (TTM) N/A
GM 17.66%
OM growth 3Y-31.88%
OM growth 5Y-30.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.12%
GM growth 5Y-8.31%
MATV Yearly Profit, Operating, Gross MarginsMATV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MATV is destroying value.
Compared to 1 year ago, MATV has more shares outstanding
MATV has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MATV is higher compared to a year ago.
MATV Yearly Shares OutstandingMATV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
MATV Yearly Total Debt VS Total AssetsMATV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

MATV has an Altman-Z score of 1.28. This is a bad value and indicates that MATV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.28, MATV is doing worse than 74.70% of the companies in the same industry.
MATV has a debt to FCF ratio of 24.06. This is a negative value and a sign of low solvency as MATV would need 24.06 years to pay back of all of its debts.
MATV's Debt to FCF ratio of 24.06 is in line compared to the rest of the industry. MATV outperforms 45.78% of its industry peers.
MATV has a Debt/Equity ratio of 2.65. This is a high value indicating a heavy dependency on external financing.
MATV's Debt to Equity ratio of 2.65 is on the low side compared to the rest of the industry. MATV is outperformed by 85.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF 24.06
Altman-Z 1.28
ROIC/WACC0.15
WACC9.76%
MATV Yearly LT Debt VS Equity VS FCFMATV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

MATV has a Current Ratio of 2.37. This indicates that MATV is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.37, MATV is in the better half of the industry, outperforming 65.06% of the companies in the same industry.
MATV has a Quick Ratio of 1.21. This is a normal value and indicates that MATV is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.21, MATV is in line with its industry, outperforming 46.99% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 1.21
MATV Yearly Current Assets VS Current LiabilitesMATV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The earnings per share for MATV have decreased strongly by -43.75% in the last year.
Measured over the past years, MATV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -29.46% on average per year.
The Revenue has decreased by -0.36% in the past year.
MATV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.14% yearly.
EPS 1Y (TTM)-43.75%
EPS 3Y-38.46%
EPS 5Y-29.46%
EPS Q2Q%-2.94%
Revenue 1Y (TTM)-0.36%
Revenue growth 3Y11.22%
Revenue growth 5Y14.14%
Sales Q2Q%0.31%

3.2 Future

Based on estimates for the next years, MATV will show a very strong growth in Earnings Per Share. The EPS will grow by 27.84% on average per year.
The Revenue is expected to grow by 1.28% on average over the next years.
EPS Next Y3.65%
EPS Next 2Y31.74%
EPS Next 3Y27.84%
EPS Next 5YN/A
Revenue Next Year-0.05%
Revenue Next 2Y1.38%
Revenue Next 3Y1.03%
Revenue Next 5Y1.28%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MATV Yearly Revenue VS EstimatesMATV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
MATV Yearly EPS VS EstimatesMATV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 26.11, MATV can be considered very expensive at the moment.
MATV's Price/Earnings ratio is in line with the industry average.
MATV's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.41.
Based on the Price/Forward Earnings ratio of 10.92, the valuation of MATV can be described as reasonable.
Based on the Price/Forward Earnings ratio, MATV is valued a bit cheaper than the industry average as 74.70% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of MATV to the average of the S&P500 Index (22.87), we can say MATV is valued rather cheaply.
Industry RankSector Rank
PE 26.11
Fwd PE 10.92
MATV Price Earnings VS Forward Price EarningsMATV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MATV indicates a somewhat cheap valuation: MATV is cheaper than 62.65% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, MATV is valued cheaper than 81.93% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.93
EV/EBITDA 9.57
MATV Per share dataMATV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
MATV's earnings are expected to grow with 27.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.16
PEG (5Y)N/A
EPS Next 2Y31.74%
EPS Next 3Y27.84%

3

5. Dividend

5.1 Amount

MATV has a Yearly Dividend Yield of 3.14%.
Compared to an average industry Dividend Yield of 3.47, MATV pays a bit more dividend than its industry peers.
MATV's Dividend Yield is a higher than the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.14%

5.2 History

The dividend of MATV decreases each year by -25.76%.
MATV has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-25.76%
Div Incr Years0
Div Non Decr Years0
MATV Yearly Dividends per shareMATV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

5.3 Sustainability

MATV has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-4.88%
EPS Next 2Y31.74%
EPS Next 3Y27.84%
MATV Yearly Income VS Free CF VS DividendMATV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

MATIV HOLDINGS INC

NYSE:MATV (9/23/2025, 3:23:04 PM)

11.75

-0.44 (-3.61%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners91.1%
Inst Owner ChangeN/A
Ins Owners0.92%
Ins Owner Change16.85%
Market Cap642.37M
Analysts85.71
Price Target15.81 (34.55%)
Short Float %1.09%
Short Ratio0.92
Dividend
Industry RankSector Rank
Dividend Yield 3.14%
Yearly Dividend0.4
Dividend Growth(5Y)-25.76%
DP-4.88%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-29 2025-08-29 (0.1)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)27.48%
Min EPS beat(2)-24.78%
Max EPS beat(2)79.74%
EPS beat(4)2
Avg EPS beat(4)43.73%
Min EPS beat(4)-25.13%
Max EPS beat(4)145.1%
EPS beat(8)5
Avg EPS beat(8)42.39%
EPS beat(12)6
Avg EPS beat(12)28.29%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.53%
Min Revenue beat(2)1.06%
Max Revenue beat(2)2%
Revenue beat(4)2
Avg Revenue beat(4)-2.71%
Min Revenue beat(4)-7.08%
Max Revenue beat(4)2%
Revenue beat(8)2
Avg Revenue beat(8)-3.46%
Revenue beat(12)3
Avg Revenue beat(12)-3.27%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)19.23%
PT rev (3m)19.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.9%
EPS NY rev (1m)0%
EPS NY rev (3m)2.44%
Revenue NQ rev (1m)-33.6%
Revenue NQ rev (3m)-3.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.59%
Valuation
Industry RankSector Rank
PE 26.11
Fwd PE 10.92
P/S 0.33
P/FCF 13.93
P/OCF 6.21
P/B 1.54
P/tB N/A
EV/EBITDA 9.57
EPS(TTM)0.45
EY3.83%
EPS(NY)1.08
Fwd EY9.16%
FCF(TTM)0.84
FCFY7.18%
OCF(TTM)1.89
OCFY16.1%
SpS35.99
BVpS7.62
TBVpS-3.43
PEG (NY)7.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.89%
ROE -109.1%
ROCE 1.85%
ROIC 1.46%
ROICexc 1.55%
ROICexgc 2.41%
OM 1.68%
PM (TTM) N/A
GM 17.66%
FCFM 2.34%
ROA(3y)-4.64%
ROA(5y)-1%
ROE(3y)-13%
ROE(5y)-2.64%
ROIC(3y)1.6%
ROIC(5y)3.28%
ROICexc(3y)1.67%
ROICexc(5y)3.41%
ROICexgc(3y)3.34%
ROICexgc(5y)7.27%
ROCE(3y)2.03%
ROCE(5y)4.15%
ROICexcg growth 3Y-27.26%
ROICexcg growth 5Y-28.59%
ROICexc growth 3Y-23.81%
ROICexc growth 5Y-28.43%
OM growth 3Y-31.88%
OM growth 5Y-30.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.12%
GM growth 5Y-8.31%
F-Score4
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF 24.06
Debt/EBITDA 6.29
Cap/Depr 40.18%
Cap/Sales 2.91%
Interest Coverage 0.38
Cash Conversion 58.88%
Profit Quality N/A
Current Ratio 2.37
Quick Ratio 1.21
Altman-Z 1.28
F-Score4
WACC9.76%
ROIC/WACC0.15
Cap/Depr(3y)43.24%
Cap/Depr(5y)43.56%
Cap/Sales(3y)2.94%
Cap/Sales(5y)2.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.75%
EPS 3Y-38.46%
EPS 5Y-29.46%
EPS Q2Q%-2.94%
EPS Next Y3.65%
EPS Next 2Y31.74%
EPS Next 3Y27.84%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.36%
Revenue growth 3Y11.22%
Revenue growth 5Y14.14%
Sales Q2Q%0.31%
Revenue Next Year-0.05%
Revenue Next 2Y1.38%
Revenue Next 3Y1.03%
Revenue Next 5Y1.28%
EBIT growth 1Y27.41%
EBIT growth 3Y-24.24%
EBIT growth 5Y-20.26%
EBIT Next Year4232.08%
EBIT Next 3Y267.29%
EBIT Next 5YN/A
FCF growth 1Y-61.9%
FCF growth 3Y26.86%
FCF growth 5Y-20.85%
OCF growth 1Y-49.24%
OCF growth 3Y17.73%
OCF growth 5Y-9.97%